Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Fax+1 713-745-1782
Are you Dr. Bhalla?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kapil Bhalla, MD is an oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Florida, and Georgia.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 1980 - 1983
New York Medical College at St Michael's Medical CenterResidency, Internal Medicine, 1977 - 1980- St Michael's Medical CenterInternship, Transitional Year, 1976 - 1977
Maulana Azad Medical CollegeClass of 1976
Certifications & Licensure
NY State Medical License 1980 - Present
FL State Medical License 1999 - 2025
TX State Medical License 2017 - 2025
GA State Medical License 1995 - 2013
SC State Medical License 1989 - 2013
NJ State Medical License 1977 - 1993
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsPreclinical efficacy of CDK7 inhibitor-based combinations against myeloproliferative neoplasms transformed to AML.Warren Fiskus, Christopher P Mill, Prithviraj Bose, Lucia Masarova, Naveen Pemmaraju
Blood. 2025-02-06 - 3 citationsMenin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the internatio...Branko Cuglievan, Hagop Kantarjian, Jeffrey E Rubnitz, Todd M Cooper, C Michel Zwaan
Leukemia. 2024-10-01 - 13 citationsBRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor.Warren Fiskus, Jessica Piel, Mike Collins, Murphy Hentemann, Branko Cuglievan
Blood. 2024-05-16
Press Mentions
Two Muslim Doctors Become First Donors of Plasma in Indore for Trial Treatment of Covid-19 PatientsApril 27th, 2020
MD Anderson Research Highlights AACR 2024 Special EditionApril 6th, 2024
Grant Support
- Novel combination therapy for AML expressing mutant RUNX1UNIVERSITY OF TX MD ANDERSON CAN CTR2021–2025
- Novel combination therapy for AML expressing mutant RUNX1UNIVERSITY OF TX MD ANDERSON CAN CTR2021–2025
- Biology and novel therapy of AML expressing somatic or germline mutant RUNX1UNIVERSITY OF TX MD ANDERSON CAN CTR2020–2025
- Targeting dysregulated transcriptome as therapy for post-myeloproliferative neoplasm (MPN) sAMLUNIVERSITY OF TX MD ANDERSON CAN CTR2020–2025
- Biology and novel therapy of AML expressing somatic or germline mutant RUNX1UNIVERSITY OF TX MD ANDERSON CAN CTR2020–2025
- Biology and novel therapy of AML expressing somatic or germline mutant RUNX1UNIVERSITY OF TX MD ANDERSON CAN CTR2020–2025
